Rx Radio
ArticlesPodcastResourcesDataShop
Listen
Topics
NewsBusinessTechnologyClinical PracticeCommunity PharmacyDrug Pricing and AccessEducationEducation and TrainingGlobal HealthLaw and ComplianceLeadership and DevelopmentManaged CareOTC ProductsPatient Care & CounselingPharmacy TechnologyPublic HealthResearch and DevelopmentAll topics
  1. Home
  2. /Clinical Practice
  3. /FDA Approves First Nasal Spray for Anaph…
Clinical PracticeAugust 9, 2024

FDA Approves First Nasal Spray for Anaphylaxis Treatment

FDA approves Neffy, the first epinephrine nasal spray for anaphylaxis treatment, offering a needle-free alternative to injections with comparable efficacy for emergency care.

By Richard Waithe, PharmD
FDA Approves First Nasal Spray for Anaphylaxis Treatment
#Drug Safety & Recalls#FDA Approvals#Tech

Keep reading

Related Articles

Lilly Launches Zepbound KwikPen: A Multi-Dose Monthly Option for Weight Management

Clinical Practice

Lilly Launches Zepbound KwikPen: A Multi-Dose Monthly Option for Weight Management

FDA Approves YUVEZZI: First Dual-Agent Eye Drop for Age-Related Near Vision Loss

Clinical Practice

FDA Approves YUVEZZI: First Dual-Agent Eye Drop for Age-Related Near Vision Loss

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know

Clinical Practice

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know

Related Articles

  1. 01

    Lilly Launches Zepbound KwikPen: A Multi-Dose Monthly Option for Weight Management

  2. 02

    FDA Approves YUVEZZI: First Dual-Agent Eye Drop for Age-Related Near Vision Loss

  3. 03

    Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know

Rx Radio

Leading the conversation in pharmacy.

Listen to the podcastVisit the shop

Explore

  • Articles
  • Podcast
  • Resources
  • Data
  • Categories
  • Search

Topics

  • News
  • Business
  • Technology
  • Clinical Practice
  • Community Pharmacy
  • Drug Pricing and Access
  • Education

Company

  • About
  • Privacy Policy
  • Terms of Service

Follow

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Threads

© 2026 Rx Radio. All rights reserved.

PrivacyTerms

Rx Radio